Psilocybin Therapy for Psychological Distress in Palliative Patients

NCT06782724 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

COPD (Chronic Obstructive Pulmonary Disease)
ALS (Amyotrophic Lateral Sclerosis)
MS (Multiple Sclerosis)
Major Depressive Disorder (MDD)
Atypical Parkinson Disease

Interventions

DRUG: Psilocybin therapy

Sponsor

University Medical Center Groningen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]